Research Initiatives

To support our advocacy work, the Ontario Pharmacists Association conducts research that provides analyses of the state of health care in the province, and the current and potential contribution of pharmacists. OPA's Health Policy and Research team is vital in leading this research for the pharmacy profession. Here you will find some of its active or completed work including external projects that have sought OPA’s expertise and feedback as a knowledge user i.e., an organization that can use the knowledge generated by the project.

Summary of active projects
Summary of completed projects
Summary of OPA led reports

 For questions or more information about any of OPA’s reports or studies, please email info@opatoday.com.

Summary of active projects

Status

Asthma Project

  • OPA is collaborating with Ryerson University and overseeing this project that is being completed by a master's student
  • Funded by sponsors

Active;

expected completion date is September 2018


Summary of completed projects

Presentations

Date

The Ontario Naloxone Program for Pharmacies. The Ontario Public Health Convention. March 21-23, 2018
Canadian Pharmacists Perspectives on Medical Assistance in Dying. Bioethics Seminar, Joint Centre for Bioethics. (Link) January 10, 2018
Pharmacists’ Perspectives on the Ontario Naloxone Pharmacy Program. Health Quality Ontario Conference. October 24, 2017
Resources to facilitate naloxone dispensing in community pharmacy. OPEN Summit. October 4, 2017
Pharmacists’ Perspectives on the Ontario Naloxone Pharmacy Program. Ontario Pharmacists Association Annual Conference. June 15-17, 2017
Pharmacists, Pharmacies and Marijuana: Opportunities and Challenges.  Ontario Pharmacists Association Annual Conference. June 15-17, 2017
Recruitment Challenges of a Pharmacist-led Asthma Intervention Program. Better Breathing Conference. January 27, 2017
Pharmacists, Pharmacies and Medical Marijuana: Opportunities and Challenges. Bioethics Seminar, Joint Centre for Bioethics. (Link) December 7, 2016
Community Pharmacists’ Perspectives on Shared Decision Making within Diabetes Management.  OPEN Showcase. November 7, 2016
Evaluation of the Impact of an Expanded Immunization Program. Ontario Pharmacists Association Annual Conference. June 9-11, 2016
Pharmacists’ Perceptions of an Online Travel Health Tool. Accepted for poster presentation. Ontario Pharmacists Association Annual Conference. June 9-11, 2016
Pharmacists’ Perspectives on Shared Decision Making and a Diabetes Decision Aid. Accepted for poster presentation. Ontario Pharmacists Association Annual Conference. June 9-11, 2016

Publications

Date

The Role of Community Pharmacists as Antimicrobial Stewards. Canadian Journal of Public Health.  (Link) September 2018 
The North American Opioid Experience and the Role of Community Pharmacy. Journal of Public Health Management and Practice. (link) July/August 2018
Medical Assistance in Dying: A Pharmacy Perspective.  Canadian Pharmacists Journal.  Canadian Pharmacists Journal (link) February 2018
Community Pharmacists’ Perspectives of a Decision Aid for Managing Diabetes in Ontario. Canadian Journal of Diabetes. (link) December 2017
Community Pharmacists' Perspectives on Shared Decision Making in Diabetes Management. International Journal of Pharmaceutics. (link) December 2017

Collaborations

Date

Myocardial Infarction Prescription Adherence Duration (MIPAD) Study. (J-D Schwalm)

Role: Knowledge user

Summer 2019

Optimizing support and service delivery for problem gambling among people living with complex needs (Flora Matheson and Sara Guilcher)

Role: Knowledge user

Spring 2019 

Should community pharmacy be “linked”? A pilot study exploring perceptions of the integration of community pharmacy with Health Links in Ontario (Sara Guilcher, Jennifer Lake Katie Dainty)

Role: Team member

December 2019  

University of Waterloo, project on travel medicines (Sherilyn Houle)

Role: Knowledge user

Fall 2018 

Informing an 'all hands-on deck' approach to the opioid crisis: A systematic review of the effectiveness of prevention, treatment, harm reduction, and enforcement strategies to prevent and reduce opioid-related harms. (Nancy Carnide, Andrea Furlan and Emma Irvin, Institute for Work & Health)

Role: Knowledge user

Fall 2018 

The buzz on cannabis and the opioid crisis: Scoping the literature to understand the relationship between cannabis and opioid use and related harms. (Nancy Carnide, Andrea Furlan and Emma Irvin, Institute for Work & Health)

 

Role: Knowledge user

Fall 2018

CLEAN Meds RCT: Carefully seLected and Easily Accessible at No charge Medications. (Nav Persaud)

 

Role: Knowledge user

April 2018

Ontario Pharmacy Research Collaboration (OPEN) Projects:

 

1. Smoking Cessation

Role: AHRQ KU submitter

 

2. Incorporating community pharmacists into Community Health Links

Role: KU submitter and member of the investigator team

 

3. The role of outreach & practice facilitation in pharmacy services training

Role: AHRQ KU submitter

 

4. MedsCheck and Pharmaceutical Opinion Programs

Role: Collaborator

 

5. Pharmacists as immunizers

Role: project member

 

6. Smoking cessation 2.0

Role: Applied health research question (AHRQ) knowledge user (KU) submitter

 

7. Development of a diabetes decision aid for use by patients and pharmacists

Role: Principal investigator

 

8. Pharmacists prescribing

Role: project member
2014-2015

Summary of OPA led reports

Date

Evaluation of the Impact of an Expanded Immunization Program
Human Papillomavirus (HPV) Addendum 

  • OPA commissioned RiskAnalytica to explore whether or not a business case exists to support education for, and access to immunizations administered by pharmacists for the following diseases 
  • Funded by sponsors

2015-16

White Paper on Pharmacists Billing Numbers and Alternate Models of Reimbursement

  • Work led by volunteer task force, headed by member Dean Miller, and supported by OPA staff and committees
  • Goal was to provide insights and options on potential reimbursement models that support compensation of pharmacists for professional services.

2014

Report on the impact of community pharmacist interventions in hypertension management (Full Report) Exeucitve Summary

  • OPA collaborated with Green Sheild to release study that shows pharmacists can play a key role in helping patients with hypertension improve their health by substantially lowering their blood pressure.

2014

Report on the retrospective evaluation of drug therapy recommendations made by pharmacists

  • Study that identifies successes and areas of improvement of the program in its first two years of existence
  • Funded by Eli Lilly Canada and LifeScan Canada Ltd

2013

Report on the value of expanded pharmacist authority (2012) Executive Summary

  • Landmark study that shows that Ontario could realize health system savings of at least $143 million between 2013 and 2017 by fully implementing and funding pharmacists’ authority in five key practice areas: counselling and prescribing for smoking cessation; administering flu vaccinations; adapting patients’ drug therapy; renewing prescriptions for stable chronic conditions; and prescribing for minor ailments.

2012

Report on the value of pharmacy (2009) - Full Report Executive Summary Methodology Economic Model Framework Workflows References

  • OPA engaged the services of nD Insight Corporation to analyse five specific service categories under the umbrella of medication therapy management: health, wellness and disease education programs; refills of chronic care medications; therapeutic modification; prescription intervention; and minor ailments program.

2009

Report on contribution to long-term care (Final Report)  Letter to MOHLTC

  • OPA and the Canadian Association of Chain Drug Stores (CACDS) commissioned a study by MentoRx to analyze the extra costs incurred by pharmacies to serve residents of the province’s long-term care facilities, including nursing homes, homes for the aged, and charitable homes.

2009

Back to top